PFM Health Sciences’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

PFM Health Sciences’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-469,664	Closed	-$15.9M	–	104
2021 Q2	$15.9M	Hold	469,664	–	–	0.5%	54
2021 Q1	$11M	Hold	469,664	–	–	0.34%	62
2020 Q4	$13.5M	Sell	469,664 -825,313	-64%	-$20.8M	0.48%	65
2020 Q3	$26.2M	Buy	1,294,977 +243,587	+23%	+$5.95M	1.21%	31
2020 Q2	$31.6M	Buy	1,051,390 +735,496	+233%	+$26.5M	1.64%	24
2020 Q1	$9.93M	Buy	+315,894	New	+$11M	0.82%	41

PFM Health Sciences's CNST Position: Q3 2021 in Review

PFM Health Sciences sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 469,664 shares — an estimated $15.9M sold.

PFM Health Sciences first reported a position in CNST in Q1 2020 and held it in 6 quarters. The position peaked at $31.6M in Q2 2020. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

PFM Health Sciences reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
PFM Health Sciences sold 469,664 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $15.9M.
PFM Health Sciences first reported a position in Constellation Pharmaceuticals, Inc. in Q1 2020 and held it in 6 quarters.
PFM Health Sciences's Constellation Pharmaceuticals, Inc. position peaked at $31.6M in Q2 2020.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on PFM Health Sciences's 13F filing for Q3 2021, filed 15 Nov 2021.